Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.085 USD | +1.87% | +3.80% | +313.10% |
06-25 | Rezolute, Inc. announced that it expects to receive $6 million in funding | CI |
06-14 | Rezolute Shares Decline After Company Prices $60 Million Public Offering | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
REZOLUTE, INC. | Bio Therapeutic Drugs | +2.24% | +3.80% | +313.10% | +105.00% | -58.59% | 206M |
Technical Rankings Surperformance
- Stock Market
- Equities
- RZLT Stock
- Charts Rezolute, Inc.
- Comparison Chart